CVS Health shares surged 57% between June 30, 2025 and July 1, 2026, after management explicitly laid out a turnaround plan for its Aetna insurance unit. The finance chief told investors there were $3 to $4 of embedded adjusted EPS if the Aetna business returned to target margins, and later noted each point of margin recovery was worth $0.75 of adjusted EPS. The plan involved trimming Medicare Advantage membership by 5% to 10% and exiting individual ACA exchange plans to eliminate $350 million to $400 million in projected annual losses. In fiscal Q1 2025, the Health Care Benefits segment's operating income jumped over $1.2 billion year-over-year, with the medical benefit ratio improving to 87.3%, prompting the company to raise full-year 2025 guidance.
CVS Health CorpManagement quantified $3-$4 embedded EPS from Aetna turnaround, raised 2025 guidance after strong Q1 results.
Elevance Health Inc
Humana Inc
UnitedHealth Group Incorporated
Walmart Inc.